CM Management LLC Lowers Holdings in Gain Therapeutics, Inc. (NASDAQ:GANX)
CM Management LLC trimmed its holdings in Gain Therapeutics, Inc. (NASDAQ:GANX – Get Rating) by 12.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 110,000 shares of the company’s stock after selling 15,000 shares during the quarter. CM Management LLC’s holdings in […]